| 000 | 01628 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250511180432.0 | ||
| 264 | 0 | _c19921110 | |
| 008 | 199211s 0 0 eng d | ||
| 022 | _a0024-4201 | ||
| 024 | 7 |
_a10.1007/BF02536114 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDomingo, M T | |
| 245 | 0 | 0 |
_aReversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists. _h[electronic resource] |
| 260 |
_bLipids _cAug 1992 |
||
| 300 |
_a582-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAzepines _xpharmacology |
| 650 | 0 | 4 |
_aBlood Platelets _xmetabolism |
| 650 | 0 | 4 |
_aCell Membrane _xmetabolism |
| 650 | 0 | 4 |
_aDioxolanes _xpharmacology |
| 650 | 0 | 4 | _aDiterpenes |
| 650 | 0 | 4 |
_aFurans _xpharmacology |
| 650 | 0 | 4 | _aGinkgolides |
| 650 | 0 | 4 |
_aLactones _xpharmacology |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPlatelet Activating Factor _xanalogs & derivatives |
| 650 | 0 | 4 | _aPlatelet Membrane Glycoproteins |
| 650 | 0 | 4 |
_aPyridinium Compounds _xpharmacology |
| 650 | 0 | 4 |
_aQuinolinium Compounds _xpharmacology |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xantagonists & inhibitors |
| 650 | 0 | 4 | _aReceptors, G-Protein-Coupled |
| 650 | 0 | 4 |
_aTriazoles _xpharmacology |
| 650 | 0 | 4 | _aTritium |
| 700 | 1 | _aPiro, F | |
| 700 | 1 | _aBroquet, C | |
| 700 | 1 | _aAuclair, E | |
| 700 | 1 | _aChabrier, P E | |
| 700 | 1 | _aBraquet, P | |
| 773 | 0 |
_tLipids _gvol. 27 _gno. 8 _gp. 582-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02536114 _zAvailable from publisher's website |
| 999 |
_c1335321 _d1335321 |
||